查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595065

微生物组定序服务的全球市场

Microbiome Sequencing Services
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球微生物组定序服务市场将达到 55 亿美元

微生物组定序服务的全球市场预计 2023 年为 17 亿美元，预计到 2030 年将达到 55 亿美元，在 2023-2030 年分析期间复合年增长率为 18.1%。合成技术是本报告分析的细分市场之一，预计复合年增长率为 16.8%，到分析期结束时将达到 23 亿美元。分析期间，连接技术领域的复合年增长率预计为14.7%。

美国市场预估为4.762亿美元，中国预期复合年增长率为17.3%

预计 2023 年美国微生物组定序服务市场规模将达 4.762 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达到8.421亿美元，2023-2030年分析期间复合年增长率为17.3%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间复合年增长率分别为 15.8% 和 15.5%。在欧洲，德国的复合年增长率预计约为 13.2%。

全球微生物组定序服务市场—主要趋势与驱动因素总结

什么是微生物组定序服务？

微生物组定序服务利用先进的定序技术来分析和表征人体、土壤、水和植物等各种环境中存在的微生物群落。这些服务提供了对微生物组的组成、多样性和功能的详细了解，微生物组由细菌、病毒、真菌和其他微生物组成。我们使用 16S rRNA 定序、鸟枪法宏基因组学和全基因组定序等技术来破解微生物的遗传物质，以揭示它们在健康、疾病、农业和环境中的作用。

微生物组分析的重要性在于其能够揭示微生物在人类健康、疾病预防、营养、农业和生态系统平衡中所扮演的重要角色。在医疗保健领域，微生物组分析为个人化医疗和开发针对胃肠道疾病、代谢性疾病、自体免疫疾病甚至精神疾病等疾病的标靶治疗铺平了道路。在农业中，它有助于改善土壤健康、作物产量和植物抗病性。随着我们对微生物组的理解不断进步，研究正在成为临床研究和环境管理的重要工具。

技术进步如何形塑微生物组定序服务市场？

技术进步大大提高了微生物组定序服务的准确性、速度和成本效益，推动了医疗保健、农业和环境科学领域的创新。关键进展之一是采用下一代定序 (NGS)平台，该平台以低成本提供高通量、快速定序功能。 Illumina定序、Oxford Nanopore 定序和 PacBio 定序等NGS 技术可提供对微生物多样性和功能的详细了解，从而能够对复杂微生物组进行更全面的分析。这扩大了微生物组定序在个人化医疗、药物开发和诊断的应用。

鸟枪法宏基因组学的兴起进一步提高了微生物组定序服务的能力。与标靶 16S rRNA 定序不同，鸟枪法宏基因组学对样本中的所有遗传物质进行定序，从而可以更详细地了解微生物组成，包括已知物种和新物种。它还提供功能见解，例如微生物代谢途径和基因表现。这对于了解微生物组如何影响健康、疾病和生态系统平衡至关重要。该技术有助于阐明微生物在免疫调节、营养吸收和药物代谢中的作用，支持临床研究和治疗开发。

生物资讯学和资料分析的进步也在塑造微生物组定序市场方面发挥关键作用。强大的生物资讯工具和机器学习演算法使研究人员能够处理大量序列资料，识别微生物分类群，预测功能途径，并将微生物组概况与特定的健康状况和环境参数相关联，现在您可以做到。这改善了复杂微生物组资料的解释，使定序服务对于临床、农业和生态学应用更加实用和有用。此外，云端基础的平台的发展使得共用、储存和分析微生物组资料变得更加容易，从而实现全球协作和更有效率的研究。这些创新不仅扩展了微生物组定序服务的能力，而且符合精准医疗、永续农业和环境监测等更广泛的趋势。

微生物组定序服务在各领域有哪些新应用？

由于需要更深入地了解微生物在健康、疾病、农业和环境永续性中的作用，微生物组定序服务正在扩大其在各个领域的应用。在医疗保健领域，微生物组定序用于研究人类微生物组，特别是肠道、皮肤、口腔和呼吸道。这使得开发针对大肠激躁症（IBS）、肥胖、糖尿病和发炎性肠道疾病（IBD）等疾病的个人化治疗成为可能。对肠道微生物群进行定序可以识别益生菌、益生元和饮食干预的目标有益细菌，从而实现个人化营养和肠道健康管理。

在製药业，微生物组序列分析用于药物发现和药物开发。透过分析微生物组如何影响药物代谢和患者反应，製药公司可以开发更有针对性的治疗方法并减少副作用。这种方法对于开发基于微生物组的疗法特别有用，该疗法使用活细菌和微生物代谢物来治疗困难梭状芽孢桿菌传染病、溃疡性大肠炎和异位性皮肤炎等疾病。微生物组的序列分析也透过识别可用作抗原的微生物成分来支持疫苗开发，有助于预防感染疾病。

在农业中，微生物组定序用于提高作物产量、改善土壤健康以及开发植物病害生物防治剂。帮助辨识有益的土壤微生物，增强养分吸收、促进植物生长并抑制病原生物。定序服务可以创建微生物群落，将其添加到土壤和种子中，以提高作物性能和復原力，并支持永续农业实践。在环境领域，微生物组序列分析支持利用微生物降解土壤和水中污染物的生物修復工作。它还透过分析由于污染、气候变迁和栖息地破坏等因素造成的微生物多样性变化来支持生态系统监测。微生物组定序的不断增长的应用领域凸显了微生物组定序在推动创新、改善结果和支持人类健康和环境永续性方面的重要性。

微生物组定序服务市场成长的驱动力是什么？

微生物组定序服务市场的成长受到多种因素的推动，包括个人化医疗需求的增加、微生物组研究投资的增加以及定序技术的进步。主要成长要素之一是人们对人类微生物组及其对健康和疾病影响的兴趣日益浓厚。随着微生物组组成与各种健康状况之间的关係不断被阐明，临床和研究环境中对微生物组定序的需求正在增加。这种需求在肠道健康等领域尤其强劲，其中针对微生物组的治疗和诊断正在成为精准医学的主流。

微生物组研究投资的增加进一步推动了对定序服务的需求。政府、製药公司和生技公司正在大力投资微生物组计划，以支持新药、益生菌和诊断工具的开发。此外，专注于抗菌素抗药性、肠道健康和代谢疾病的公共卫生倡议正在导致微生物组研究的资金增加，从而推动了对提供详细微生物见解的测序服务的需求。

定序技术和生物资讯学的进步也促进了市场的成长。高通量、经济高效的测序平台的开发使研究人员、医疗保健提供者和农业相关企业更容易获得微生物组测序。生物资讯工具的改进增强了对复杂微生物组资料的解释，使得更容易将定序结果转化为临床、农业和环境应用的可行见解。此外，消费者微生物组测试的兴起提高了公众对个人微生物组分析的认识和兴趣，并支持了消费者健康和保健市场的成长。

随着定序、资料分析和基于微生物组的治疗方法技术创新的进步，微生物组定序服务市场有望强劲成长。这些趋势，加上对精准医疗、永续农业和环境监测不断增长的需求，使得微生物组定序成为促进人类健康、提高农业生产力和支持各部门生态系统平衡的一个重要组成部分。 。

部分

应用（製药、学术/研究机构、生物技术）；技术（合成、连接、焦磷酸测序、桑格测序和其他技术）

受访企业范例（44家知名企业）

  • AnimalBiome
  • Arranta Bio
  • BIOHM
  • Biom Pharmaceutical Corporation
  • BioMathematica
  • BiomeSense
  • Biomesight
  • BIOMx
  • Biose Industry
  • Biotage AB

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP16589

Global Microbiome Sequencing Services Market to Reach US$5.5 Billion by 2030

The global market for Microbiome Sequencing Services estimated at US$1.7 Billion in the year 2023, is expected to reach US$5.5 Billion by 2030, growing at a CAGR of 18.1% over the analysis period 2023-2030. Synthesis Technique, one of the segments analyzed in the report, is expected to record a 16.8% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the Ligation Technique segment is estimated at 14.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$476.2 Million While China is Forecast to Grow at 17.3% CAGR

The Microbiome Sequencing Services market in the U.S. is estimated at US$476.2 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$842.1 Million by the year 2030 trailing a CAGR of 17.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.8% and 15.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.2% CAGR.

Global Microbiome Sequencing Services Market - Key Trends & Drivers Summarized

What Are Microbiome Sequencing Services, and Why Are They So Crucial in Modern Genomics and Healthcare?

Microbiome Sequencing Services involve the use of advanced sequencing technologies to analyze and characterize the microbial communities found in various environments, including the human body, soil, water, and plants. These services provide detailed insights into the composition, diversity, and function of microbiomes, which consist of bacteria, viruses, fungi, and other microorganisms. Technologies like 16S rRNA sequencing, shotgun metagenomics, and whole-genome sequencing are used to decode the genetic material of microbes, uncovering their roles in health, disease, agriculture, and the environment.

The importance of microbiome sequencing lies in its ability to reveal the critical roles that microbes play in human health, disease prevention, nutrition, agriculture, and ecological balance. In healthcare, microbiome analysis has paved the way for personalized medicine, enabling the development of targeted therapies for conditions like gastrointestinal diseases, metabolic disorders, autoimmune diseases, and even mental health conditions. In agriculture, it helps improve soil health, crop yield, and plant disease resistance. As the understanding of microbiomes advances, microbiome sequencing services are becoming essential tools in both clinical research and environmental management.

How Are Technological Advancements Shaping the Microbiome Sequencing Services Market?

Technological advancements have significantly enhanced the accuracy, speed, and cost-effectiveness of Microbiome Sequencing Services, driving innovation across healthcare, agriculture, and environmental sciences. One of the major developments is the adoption of next-generation sequencing (NGS) platforms, which offer high-throughput, rapid sequencing capabilities at a lower cost. NGS technologies, including Illumina sequencing, Oxford Nanopore sequencing, and PacBio sequencing, provide detailed insights into microbial diversity and function, enabling more comprehensive analysis of complex microbiomes. This has expanded the use of microbiome sequencing in personalized medicine, drug development, and diagnostics.

The rise of shotgun metagenomics has further improved the capabilities of microbiome sequencing services. Unlike targeted 16S rRNA sequencing, shotgun metagenomics sequences all genetic material in a sample, allowing for a more detailed view of microbial composition, including both known and novel species. It also provides functional insights, such as microbial metabolic pathways and gene expression profiles, which are crucial for understanding how microbiomes influence health, disease, and ecological balance. This technology has been instrumental in uncovering microbial roles in immune modulation, nutrient absorption, and drug metabolism, supporting both clinical research and therapeutic development.

Advancements in bioinformatics and data analytics have also played a key role in shaping the microbiome sequencing market. Powerful bioinformatics tools and machine learning algorithms now enable researchers to process large volumes of sequencing data, identify microbial taxa, predict functional pathways, and correlate microbiome profiles with specific health conditions or environmental parameters. This has improved the interpretation of complex microbiome data, making sequencing services more actionable and valuable for clinical, agricultural, and ecological applications. Additionally, the development of cloud-based platforms has facilitated the sharing, storage, and analysis of microbiome data, enabling global collaboration and more efficient research. These technological innovations not only expand the capabilities of microbiome sequencing services but also align with broader trends toward precision medicine, sustainable agriculture, and environmental monitoring.

What Are the Emerging Applications of Microbiome Sequencing Services Across Different Sectors?

Microbiome Sequencing Services are finding expanding applications across various sectors, driven by the need for deeper insights into microbial roles in health, disease, agriculture, and environmental sustainability. In the healthcare sector, microbiome sequencing is used to study the human microbiome, particularly in the gut, skin, oral cavity, and respiratory tract. It enables the development of personalized treatments for conditions like irritable bowel syndrome (IBS), obesity, diabetes, and inflammatory bowel disease (IBD). Sequencing the gut microbiome helps identify beneficial bacteria that can be targeted with probiotics, prebiotics, and dietary interventions, supporting personalized nutrition and gut health management.

In the pharmaceutical industry, microbiome sequencing is used in drug discovery and development. By analyzing how microbiomes influence drug metabolism and patient response, pharmaceutical companies can develop more targeted therapies and reduce adverse drug reactions. This approach is particularly valuable in the development of microbiome-based therapeutics, which use live bacteria or microbial metabolites to treat conditions like Clostridioides difficile infection, ulcerative colitis, and atopic dermatitis. Microbiome sequencing also supports the development of vaccines by identifying microbial components that can be used as antigens, contributing to infectious disease prevention.

In the agriculture sector, microbiome sequencing is used to enhance crop yield, improve soil health, and develop biocontrol agents for plant diseases. It helps identify beneficial soil microbes that promote nutrient absorption, enhance plant growth, and suppress pathogenic organisms. Sequencing services enable the creation of microbial consortia, which are added to soil or seeds to improve crop performance and resilience, supporting sustainable farming practices. In the environmental sector, microbiome sequencing aids in bioremediation efforts, where microbes are used to break down pollutants in soil and water. It also supports ecosystem monitoring by analyzing changes in microbial diversity due to factors like pollution, climate change, and habitat destruction. The expanding applications of microbiome sequencing across these sectors highlight its critical role in driving innovation, improving outcomes, and supporting sustainability in both human health and the environment.

What Drives Growth in the Microbiome Sequencing Services Market?

The growth in the Microbiome Sequencing Services market is driven by several factors, including increasing demand for personalized medicine, rising investments in microbiome research, and technological advancements in sequencing. One of the primary growth drivers is the growing interest in the human microbiome and its impact on health and disease. As research continues to uncover links between microbiome composition and various health conditions, there is increasing demand for microbiome sequencing in both clinical and research settings. This demand is particularly strong in areas like gut health, where microbiome-targeted therapies and diagnostics are becoming mainstream in precision medicine.

Rising investments in microbiome research have further fueled demand for sequencing services. Governments, pharmaceutical companies, and biotechnology firms are investing heavily in microbiome projects, supporting the development of new drugs, probiotics, and diagnostic tools. In addition, public health initiatives focusing on antimicrobial resistance, gut health, and metabolic disorders have led to increased funding for microbiome studies, boosting demand for sequencing services that provide detailed microbial insights.

Advancements in sequencing technologies and bioinformatics have also contributed to market growth. The development of high-throughput, cost-effective sequencing platforms has made microbiome sequencing more accessible to researchers, healthcare providers, and agritech firms. Improved bioinformatics tools have enhanced the interpretation of complex microbiome data, making it easier to translate sequencing results into actionable insights for clinical, agricultural, and environmental applications. Additionally, the rise of direct-to-consumer microbiome testing has increased public awareness and interest in personal microbiome analysis, supporting market growth in consumer health and wellness.

With ongoing innovations in sequencing, data analytics, and microbiome-based therapeutics, the microbiome sequencing services market is poised for robust growth. These trends, combined with increasing demand for precision medicine, sustainable agriculture, and environmental monitoring, make microbiome sequencing a vital component of modern scientific and clinical strategies focused on improving human health, enhancing agricultural productivity, and supporting ecological balance across various sectors.

SCOPE OF STUDY:

The report analyzes the Microbiome Sequencing Services market in terms of US$ Thousand by the following End-Use; Technique, and Geographic Regions/Countries:

Segments:

End-Use (Pharmaceutical, Academic & Research Institutes, Biotech); Technique (Synthesis, Ligation, Pyrosequencing, Sanger Sequencing, Other Techniques)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • AnimalBiome
  • Arranta Bio
  • BIOHM
  • Biom Pharmaceutical Corporation
  • BioMathematica
  • BiomeSense
  • Biomesight
  • BIOMx
  • Biose Industry
  • Biotage AB

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Microbiome Sequencing Services - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Research on Gut Health Sets the Stage for Microbiome Analysis
    • Rising Incidences of Chronic Diseases Spur Demand for Microbiome Sequencing
    • Expanding Use in Cancer Research Generates Market Opportunities
    • Enhanced Accuracy and Speed of Sequencing Drives Adoption in Healthcare
    • Strong Investment in Genomics Research Crucial for Market Growth
    • Use in Drug Development Expands Microbiome Sequencing Market
    • Rising Demand for Functional Foods and Probiotics Propels Sequencing Adoption
    • Integration with AI for Predictive Analysis Strengthens Business Case
    • Expanding Applications in Dermatology Generate Demand for Sequencing Services
    • Growing Interest in Gut-Brain Axis Research Fuels Microbiome Sequencing Demand
    • Increasing Use in Nutrigenomics Generates Market Opportunities
    • Expanding Role in Infectious Disease Research Drives Sequencing Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Microbiome Sequencing Services Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Microbiome Sequencing Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Synthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for Synthesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Ligation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Ligation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pyrosequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Pyrosequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Sanger Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Sanger Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Other Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Biotech by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 19: World 7-Year Perspective for Biotech by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 23: USA 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • CANADA
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Canada 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • JAPAN
    • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Japan 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 31: Japan 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • CHINA
    • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 32: China Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: China 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 34: China Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 35: China 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • EUROPE
    • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 37: Europe 7-Year Perspective for Microbiome Sequencing Services by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Europe 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Europe 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • FRANCE
    • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 42: France Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 43: France 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 44: France Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: France 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • GERMANY
    • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 46: Germany Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Germany 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 48: Germany Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Germany 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • ITALY
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Italy 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 52: Italy Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Italy 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • UNITED KINGDOM
    • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 54: UK Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 55: UK 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 56: UK Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: UK 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 59: Rest of Europe 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 60: Rest of Europe Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Rest of Europe 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Microbiome Sequencing Services Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 64: Asia-Pacific Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Asia-Pacific 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Microbiome Sequencing Services by Technique - Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Rest of World 7-Year Perspective for Microbiome Sequencing Services by Technique - Percentage Breakdown of Value Sales for Synthesis, Ligation, Pyrosequencing, Sanger Sequencing and Other Techniques for the Years 2024 & 2030
    • TABLE 68: Rest of World Recent Past, Current & Future Analysis for Microbiome Sequencing Services by End-Use - Pharmaceutical, Academic & Research Institutes and Biotech - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of World 7-Year Perspective for Microbiome Sequencing Services by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Academic & Research Institutes and Biotech for the Years 2024 & 2030

IV. COMPETITION